INNOVADERM CRO IS NOW INDERO.
READ THE ANNOUNCEMENT
Talk to us

Study Design & Protocol Writing

Premium dermatology and rheumatology protocols built on a scientifically sound understanding of your therapeutic area and study objectives.

Let’s talk

Clinical Scientists & Physicians

0
 Years of Experience
1 +
Protocols Developed
in the Past 5 Years
50 +

High-Quality Protocol Delivery

Poorly written protocols can lead to costly protocol amendments, missed milestones, decreased data quality, site disengagement,
and poor enrollment rates. Indero’s clinical scientists collaborate with seasoned medical, regulatory, and operational experts to draft
high-quality study protocols that meet timelines and scientific standards.

Draft Protocol 

  • A clinical scientist with in-depth knowledge of dermatology and rheumatology therapeutic areas drafts the protocol using adapted tools, well-defined templates, and checklists.
 

Quality Control & Internal Review

Review by Key Opinion Leaders

  • KOLs and renowned investigators with relevant experience in your dermatology or rheumatology indication review the protocol to ensure it’s scientifically sound and practical.

Review by Innovaderm CRU

  • Protocols are also reviewed by experienced Clinical Research Coordinators from our own CRU, who understand a site’s reality, ensuring feasibility at a site level, reducing potential site protocol deviations and amendments.

Final Protocol

  • After all reviews and revisions are complete, the final protocol is produced.

Celebrating 25 Years of Therapeutic Excellence

For a quarter-century, Indero has been the trusted CRO partner for biotech and pharmaceutical leaders across the globe, delivering precision, reliability, and innovation in dermatology and rheumatology clinical trials.

Learn more

Our Proven Approach to Protocol Writing

Standardized Tools

Structured documents that are continually updated and revised as per the most recent guidelines (ICH, ethics, etc.).

Dual-Focus on Dermatology & Rheumatology

An extensive list of indication-specific clinical assessments and patient-reported outcomes (PROs).

Templates & Checklists

Built upon many years of experience in working with various dermatological and rheumatological indications.

Partner with Indero for
Study Design & Protocol Writing

Indero is a dual-focus CRO for dermatology and rheumatology clinical trials that offers a robust and collaborative study design and protocol writing process for successful clinical trials. Tell us about your clinical trial.

Let’s talk

Study Design & Protocol Writing Services that Accelerate Studies

Scientific discipline. Operational efficiency. Clinical development expertise. Our study design services provide the rigorous foundation, quality data, and expertise dermatology and rheumatology studies need to ensure effective execution and on-time delivery.

ABOUT INDERO

“Congratulations to the team for a very positive pre-IND meeting outcome! Your dedication and well-executed plans have laid a strong foundation for our program. This success is a significant trust-building milestone with the agency. Thank you for your outstanding work!”

Thibaud Portal

Founder and CEO
Alys Pharmaceuticals

Andrea Epperly

Global Head of Project Management
Alys Pharmaceuticals

Wherever
You’re Going,
We’re all in.

Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.

Talk to us

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≀3 days, and lowers costs, helping teams make informed go/no-go decisions faster.
LEARN MORE >